Estrogen

Estrogen (American English) or oestrogen (Commonwealth English; see spelling differences) is a category of sex hormone responsible for the development and regulation of the female reproductive system and secondary sex characteristics.[1][2] There are three major endogenous estrogens that have estrogenic hormonal activity: estrone (E1), estradiol (E2), and estriol (E3).[1][3] Estradiol, an estrane, is the most potent and prevalent.[1] Another estrogen called estetrol (E4) is produced only during pregnancy.

Estrogens are synthesized in all vertebrates[4] and some insects.[5] Quantitatively, estrogens circulate at lower levels than androgens in both men and women.[6] While estrogen levels are significantly lower in males than in females, estrogens nevertheless have important physiological roles in males.[7]

Like all steroid hormones, estrogens readily diffuse across the cell membrane. Once inside the cell, they bind to and activate estrogen receptors (ERs) which in turn modulate the expression of many genes.[8] Additionally, estrogens bind to and activate rapid-signaling membrane estrogen receptors (mERs),[9][10] such as GPER (GPR30).[11]

In addition to their role as natural hormones, estrogens are used as medications, for instance in menopausal hormone therapy, hormonal birth control and feminizing hormone therapy for transgender women, intersex people, and nonbinary people.

Synthetic and natural estrogens have been found in the environment and are referred to as xenoestrogens. Estrogens are among the wide range of endocrine-disrupting compounds and can cause health issues and reproductive dysfunction in both wildlife and humans.[12][13]

## Contents

* 1 Types and examples
* 2 Biological function
* 2.1 Overview of actions
* 2.2 Female pubertal development
* 2.2.1 Breast development
* 2.3 Female reproductive system
* 2.4 Neuroprotection and DNA repair
* 2.5 Brain and behavior
* 2.5.1 Sex drive
* 2.5.2 Cognition
* 2.5.3 Mental health
* 2.5.4 Parenthood
* 2.5.5 Binge eating
* 2.5.6 Masculinization in rodents
* 2.6 Skeletal system
* 2.7 Cardiovascular system
* 2.8 Immune system
* 2.9 Associated conditions
* 3 Biochemistry
* 3.1 Biosynthesis
* 3.2 Distribution
* 3.3 Metabolism
* 3.4 Excretion
* 4 Medical use
* 5 Chemistry
* 6 History
* 7 Society and culture
* 7.1 Etymology
* 7.2 Environment
* 7.3 Cosmetics
* 8 See also
* 9 References
* 10 External links

## Types and examples

v * d * e Structures of major endogenous estrogens

Estrone (E1)

Estradiol (E2)

Estriol (E3)

Estetrol (E4)

Note the hydroxyl (–OH) groups: estrone (E1) has one, estradiol (E2) has two, estriol (E3) has three, and estetrol (E4) has four.

The four major naturally occurring estrogens in women are estrone (E1), estradiol (E2), estriol (E3), and estetrol (E4). Estradiol (E2) is the predominant estrogen during reproductive years both in terms of absolute serum levels as well as in terms of estrogenic activity. During menopause, estrone is the predominant circulating estrogen and during pregnancy estriol is the predominant circulating estrogen in terms of serum levels. Given by subcutaneous injection in mice, estradiol is about 10-fold more potent than estrone and about 100-fold more potent than estriol.[14] Thus, estradiol is the most important estrogen in non-pregnant females who are between the menarche and menopause stages of life. However, during pregnancy this role shifts to estriol, and in postmenopausal women estrone becomes the primary form of estrogen in the body. Another type of estrogen called estetrol (E4) is produced only during pregnancy. All of the different forms of estrogen are synthesized from androgens, specifically testosterone and androstenedione, by the enzyme aromatase.[citation needed]

Minor endogenous estrogens, the biosyntheses of which do not involve aromatase, include 27-hydroxycholesterol, dehydroepiandrosterone (DHEA), 7-oxo-DHEA, 7α-hydroxy-DHEA, 16α-hydroxy-DHEA, 7β-hydroxyepiandrosterone, androstenedione (A4), androstenediol (A5), 3α-androstanediol, and 3β-androstanediol.[15][16] Some estrogen metabolites, such as the catechol estrogens 2-hydroxyestradiol, 2-hydroxyestrone, 4-hydroxyestradiol, and 4-hydroxyestrone, as well as 16α-hydroxyestrone, are also estrogens with varying degrees of activity.[17] The biological importance of these minor estrogens is not entirely clear.

## Biological function

Reference ranges for the blood content of estradiol, the primary type of estrogen, during the menstrual cycle[18]

The actions of estrogen are mediated by the estrogen receptor (ER), a dimeric nuclear protein that binds to DNA and controls gene expression. Like other steroid hormones, estrogen enters passively into the cell where it binds to and activates the estrogen receptor. The estrogen:ER complex binds to specific DNA sequences called a hormone response element to activate the transcription of target genes (in a study using an estrogen-dependent breast cancer cell line as model, 89 such genes were identified).[19] Since estrogen enters all cells, its actions are dependent on the presence of the ER in the cell. The ER is expressed in specific tissues including the ovary, uterus and breast. The metabolic effects of estrogen in postmenopausal women have been linked to the genetic polymorphism of the ER.[20]

While estrogens are present in both men and women, they are usually present at significantly higher levels in biological females of reproductive age. They promote the development of female secondary sexual characteristics, such as breasts, darkening and enlargement of nipples,[21] and thickening of the endometrium and other aspects of regulating the menstrual cycle. In males, estrogen regulates certain functions of the reproductive system important to the maturation of sperm[22][23][24] and may be necessary for a healthy libido.[25]

v * d * e Affinities of estrogen receptor ligands for the ERα and ERβ Ligand | Other names | Relative binding affinities (RBA, %)a | Absolute binding affinities (Ki, nM)a | Action

|
|
|
|

ERα | ERβ | ERα | ERβ
Estradiol | E2; 17β-Estradiol | 100 | 100 | Script error: The function "median" does not exist. (0.04–0.24) | Script error: The function "median" does not exist. (0.10–2.08) | Estrogen
Estrone | E1; 17-Ketoestradiol | Script error: The function "median" does not exist. (0.7–60) | Script error: The function "median" does not exist. (1.36–52) | Script error: The function "median" does not exist. (0.3–1.01) | Script error: The function "median" does not exist. (0.35–9.24) | Estrogen
Estriol | E3; 16α-OH-17β-E2 | Script error: The function "median" does not exist. (4.03–56) | Script error: The function "median" does not exist. (14.0–44.6) | Script error: The function "median" does not exist. (0.35–1.4) | Script error: The function "median" does not exist. (0.63–0.7) | Estrogen
Estetrol | E4; 15α,16α-Di-OH-17β-E2 | 4.0 | 3.0 | 4.9 | 19 | Estrogen
Alfatradiol | 17α-Estradiol | Script error: The function "median" does not exist. (7–80.1) | Script error: The function "median" does not exist. (2–42) | 0.2–0.52 | 0.43–1.2 | Metabolite
16-Epiestriol | 16β-Hydroxy-17β-estradiol | Script error: The function "median" does not exist. (4.94–63) | 50 | ? | ? | Metabolite
17-Epiestriol | 16α-Hydroxy-17α-estradiol | Script error: The function "median" does not exist. (29–103) | 79–80 | ? | ? | Metabolite
16,17-Epiestriol | 16β-Hydroxy-17α-estradiol | 1.0 | 13 | ? | ? | Metabolite
2-Hydroxyestradiol | 2-OH-E2 | Script error: The function "median" does not exist. (7–81) | 11–35 | 2.5 | 1.3 | Metabolite
2-Methoxyestradiol | 2-MeO-E2 | 0.0027–2.0 | 1.0 | ? | ? | Metabolite
4-Hydroxyestradiol | 4-OH-E2 | Script error: The function "median" does not exist. (8–70) | 7–56 | 1.0 | 1.9 | Metabolite
4-Methoxyestradiol | 4-MeO-E2 | 2.0 | 1.0 | ? | ? | Metabolite
2-Hydroxyestrone | 2-OH-E1 | 2.0–4.0 | 0.2–0.4 | ? | ? | Metabolite
2-Methoxyestrone | 2-MeO-E1 | <0.001–<1 | <1 | ? | ? | Metabolite
4-Hydroxyestrone | 4-OH-E1 | 1.0–2.0 | 1.0 | ? | ? | Metabolite
4-Methoxyestrone | 4-MeO-E1 | <1 | <1 | ? | ? | Metabolite
16α-Hydroxyestrone | 16α-OH-E1; 17-Ketoestriol | 2.0–6.5 | 35 | ? | ? | Metabolite
2-Hydroxyestriol | 2-OH-E3 | 2.0 | 1.0 | ? | ? | Metabolite
4-Methoxyestriol | 4-MeO-E3 | 1.0 | 1.0 | ? | ? | Metabolite
Estradiol sulfate | E2S; Estradiol 3-sulfate | <1 | <1 | ? | ? | Metabolite
Estradiol disulfate | Estradiol 3,17β-disulfate | 0.0004 | ? | ? | ? | Metabolite
Estradiol 3-glucuronide | E2-3G | 0.0079 | ? | ? | ? | Metabolite
Estradiol 17β-glucuronide | E2-17G | 0.0015 | ? | ? | ? | Metabolite
Estradiol 3-gluc. 17β-sulfate | E2-3G-17S | 0.0001 | ? | ? | ? | Metabolite
Estrone sulfate | E1S; Estrone 3-sulfate | <1 | <1 | >10 | >10 | Metabolite
Estradiol benzoate | EB; Estradiol 3-benzoate | 10 | ? | ? | ? | Estrogen
Estradiol 17β-benzoate | E2-17B | 11.3 | 32.6 | ? | ? | Estrogen
Estrone methyl ether | Estrone 3-methyl ether | 0.145 | ? | ? | ? | Estrogen
ent-Estradiol | 1-Estradiol | 1.31–12.34 | 9.44–80.07 | ? | ? | Estrogen
Equilin | 7-Dehydroestrone | Script error: The function "median" does not exist. (4.0–28.9) | 13.0–49 | 0.79 | 0.36 | Estrogen
Equilenin | 6,8-Didehydroestrone | 2.0–15 | 7.0–20 | 0.64 | 0.62 | Estrogen
17β-Dihydroequilin | 7-Dehydro-17β-estradiol | 7.9–113 | 7.9–108 | 0.09 | 0.17 | Estrogen
17α-Dihydroequilin | 7-Dehydro-17α-estradiol | Script error: The function "median" does not exist. (18–41) | 14–32 | 0.24 | 0.57 | Estrogen
17β-Dihydroequilenin | 6,8-Didehydro-17β-estradiol | 35–68 | 90–100 | 0.15 | 0.20 | Estrogen
17α-Dihydroequilenin | 6,8-Didehydro-17α-estradiol | 20 | 49 | 0.50 | 0.37 | Estrogen
Δ8-Estradiol | 8,9-Dehydro-17β-estradiol | 68 | 72 | 0.15 | 0.25 | Estrogen
Δ8-Estrone | 8,9-Dehydroestrone | 19 | 32 | 0.52 | 0.57 | Estrogen
Ethinylestradiol | EE; 17α-Ethynyl-17β-E2 | Script error: The function "median" does not exist. (68.8–480) | Script error: The function "median" does not exist. (2.0–144) | 0.02–0.05 | 0.29–0.81 | Estrogen
Mestranol | EE 3-methyl ether | ? | 2.5 | ? | ? | Estrogen
Moxestrol | RU-2858; 11β-Methoxy-EE | 35–43 | 5–20 | 0.5 | 2.6 | Estrogen
Methylestradiol | 17α-Methyl-17β-estradiol | 70 | 44 | ? | ? | Estrogen
Diethylstilbestrol | DES; Stilbestrol | Script error: The function "median" does not exist. (89.1–468) | Script error: The function "median" does not exist. (61.2–295) | 0.04 | 0.05 | Estrogen
Hexestrol | Dihydrodiethylstilbestrol | Script error: The function "median" does not exist. (31–302) | 60–234 | 0.06 | 0.06 | Estrogen
Dienestrol | Dehydrostilbestrol | Script error: The function "median" does not exist. (20.4–223) | 56–404 | 0.05 | 0.03 | Estrogen
Benzestrol (B2) | – | 114 | ? | ? | ? | Estrogen
Chlorotrianisene | TACE | 1.74 | ? | 15.30 | ? | Estrogen
Triphenylethylene | TPE | 0.074 | ? | ? | ? | Estrogen
Triphenylbromoethylene | TPBE | 2.69 | ? | ? | ? | Estrogen
Tamoxifen | ICI-46,474 | Script error: The function "median" does not exist. (0.1–47) | Script error: The function "median" does not exist. (0.28–6) | 3.4–9.69 | 2.5 | SERM
Afimoxifene | 4-Hydroxytamoxifen; 4-OHT | Script error: The function "median" does not exist. (1.7–257) | Script error: The function "median" does not exist. (0.98–339) | Script error: The function "median" does not exist. (0.1–3.61) | 0.04–4.8 | SERM
Toremifene | 4-Chlorotamoxifen; 4-CT | ? | ? | 7.14–20.3 | 15.4 | SERM
Clomifene | MRL-41 | Script error: The function "median" does not exist. (19.2–37.2) | 12 | 0.9 | 1.2 | SERM
Cyclofenil | F-6066; Sexovid | 151–152 | 243 | ? | ? | SERM
Nafoxidine | U-11,000A | 30.9–44 | 16 | 0.3 | 0.8 | SERM
Raloxifene | – | Script error: The function "median" does not exist. (7.8–69) | Script error: The function "median" does not exist. (0.54–16) | 0.188–0.52 | 20.2 | SERM
Arzoxifene | LY-353,381 | ? | ? | 0.179 | ? | SERM
Lasofoxifene | CP-336,156 | 10.2–166 | 19.0 | 0.229 | ? | SERM
Ormeloxifene | Centchroman | ? | ? | 0.313 | ? | SERM
Levormeloxifene | 6720-CDRI; NNC-460,020 | 1.55 | 1.88 | ? | ? | SERM
Ospemifene | Deaminohydroxytoremifene | 2.63 | 1.22 | ? | ? | SERM
Bazedoxifene | – | ? | ? | 0.053 | ? | SERM
Etacstil | GW-5638 | 4.30 | 11.5 | ? | ? | SERM
ICI-164,384 | – | Script error: The function "median" does not exist. (3.70–97.7) | 166 | 0.2 | 0.08 | Antiestrogen
Fulvestrant | ICI-182,780 | Script error: The function "median" does not exist. (9.4–325) | Script error: The function "median" does not exist. (2.05–40.5) | 0.42 | 1.3 | Antiestrogen
Propylpyrazoletriol | PPT | Script error: The function "median" does not exist. (10.0–89.1) | 0.12 | 0.40 | 92.8 | ERα agonist
16α-LE2 | 16α-Lactone-17β-estradiol | 14.6–57 | 0.089 | 0.27 | 131 | ERα agonist
16α-Iodo-E2 | 16α-Iodo-17β-estradiol | 30.2 | 2.30 | ? | ? | ERα agonist
Methylpiperidinopyrazole | MPP | 11 | 0.05 | ? | ? | ERα antagonist
Diarylpropionitrile | DPN | 0.12–0.25 | 6.6–18 | 32.4 | 1.7 | ERβ agonist
8β-VE2 | 8β-Vinyl-17β-estradiol | 0.35 | 22.0–83 | 12.9 | 0.50 | ERβ agonist
Prinaberel | ERB-041; WAY-202,041 | 0.27 | 67–72 | ? | ? | ERβ agonist
ERB-196 | WAY-202,196 | ? | 180 | ? | ? | ERβ agonist
Erteberel | SERBA-1; LY-500,307 | ? | ? | 2.68 | 0.19 | ERβ agonist
SERBA-2 | – | ? | ? | 14.5 | 1.54 | ERβ agonist
Coumestrol | – | Script error: The function "median" does not exist. (0.0117–94) | Script error: The function "median" does not exist. (0.41–185) | 0.14–80.0 | 0.07–27.0 | Xenoestrogen
Genistein | – | Script error: The function "median" does not exist. (0.0012–16) | Script error: The function "median" does not exist. (0.86–87) | 2.6–126 | 0.3–12.8 | Xenoestrogen
Equol | – | 0.2–0.287 | Script error: The function "median" does not exist. (0.10–2.85) | ? | ? | Xenoestrogen
Daidzein | – | Script error: The function "median" does not exist. (0.0018–9.3) | Script error: The function "median" does not exist. (0.04–17.1) | 2.0 | 85.3 | Xenoestrogen
Biochanin A | – | Script error: The function "median" does not exist. (0.022–0.15) | Script error: The function "median" does not exist. (0.010–1.2) | 174 | 8.9 | Xenoestrogen
Kaempferol | – | Script error: The function "median" does not exist. (0.029–0.10) | Script error: The function "median" does not exist. (0.002–3.00) | ? | ? | Xenoestrogen
Naringenin | – | Script error: The function "median" does not exist. (<0.001–0.01) | Script error: The function "median" does not exist. (0.11–0.33) | ? | ? | Xenoestrogen
8-Prenylnaringenin | 8-PN | 4.4 | ? | ? | ? | Xenoestrogen
Quercetin | – | <0.001–0.01 | 0.002–0.040 | ? | ? | Xenoestrogen
Ipriflavone | – | <0.01 | <0.01 | ? | ? | Xenoestrogen
Miroestrol | – | 0.39 | ? | ? | ? | Xenoestrogen
Deoxymiroestrol | – | 2.0 | ? | ? | ? | Xenoestrogen
β-Sitosterol | – | <0.001–0.0875 | <0.001–0.016 | ? | ? | Xenoestrogen
Resveratrol | – | <0.001–0.0032 | ? | ? | ? | Xenoestrogen
α-Zearalenol | – | Script error: The function "median" does not exist. (13–52.5) | ? | ? | ? | Xenoestrogen
β-Zearalenol | – | Script error: The function "median" does not exist. (0.032–13) | ? | ? | ? | Xenoestrogen
Zeranol | α-Zearalanol | 48–111 | ? | ? | ? | Xenoestrogen
Taleranol | β-Zearalanol | Script error: The function "median" does not exist. (13–17.8) | 14 | 0.8 | 0.9 | Xenoestrogen
Zearalenone | ZEN | Script error: The function "median" does not exist. (2.04–28) | Script error: The function "median" does not exist. (2.43–31.5) | ? | ? | Xenoestrogen
Zearalanone | ZAN | 0.51 | ? | ? | ? | Xenoestrogen
Bisphenol A | BPA | Script error: The function "median" does not exist. (0.008–1.0) | Script error: The function "median" does not exist. (0.002–4.23) | 195 | 35 | Xenoestrogen
Endosulfan | EDS | <0.001–<0.01 | <0.01 | ? | ? | Xenoestrogen
Kepone | Chlordecone | 0.0069–0.2 | ? | ? | ? | Xenoestrogen
o,p'-DDT | – | 0.0073–0.4 | ? | ? | ? | Xenoestrogen
p,p'-DDT | – | Script error: The function "median" does not exist. | ? | ? | ? | Xenoestrogen
Methoxychlor | p,p'-Dimethoxy-DDT | Script error: The function "median" does not exist. (<0.001–0.02) | 0.01–0.13 | ? | ? | Xenoestrogen
HPTE | Hydroxychlor; p,p'-OH-DDT | 1.2–1.7 | ? | ? | ? | Xenoestrogen
Testosterone | T; 4-Androstenolone | <0.0001–<0.01 | <0.002–0.040 | >5000 | >5000 | Androgen
Dihydrotestosterone | DHT; 5α-Androstanolone | Script error: The function "median" does not exist. (<0.001–0.05) | 0.0059–0.17 | 221–>5000 | 73–1688 | Androgen
Nandrolone | 19-Nortestosterone; 19-NT | 0.01 | 0.23 | 765 | 53 | Androgen
Dehydroepiandrosterone | DHEA; Prasterone | Script error: The function "median" does not exist. (<0.001–0.04) | 0.019–0.07 | 245–1053 | 163–515 | Androgen
5-Androstenediol | A5; Androstenediol | 6 | 17 | 3.6 | 0.9 | Androgen
4-Androstenediol | – | 0.5 | 0.6 | 23 | 19 | Androgen
4-Androstenedione | A4; Androstenedione | <0.01 | <0.01 | >10000 | >10000 | Androgen
3α-Androstanediol | 3α-Adiol | 0.07 | 0.3 | 260 | 48 | Androgen
3β-Androstanediol | 3β-Adiol | 3 | 7 | 6 | 2 | Androgen
Androstanedione | 5α-Androstanedione | <0.01 | <0.01 | >10000 | >10000 | Androgen
Etiocholanedione | 5β-Androstanedione | <0.01 | <0.01 | >10000 | >10000 | Androgen
Methyltestosterone | 17α-Methyltestosterone | <0.0001 | ? | ? | ? | Androgen
Ethinyl-3α-androstanediol | 17α-Ethynyl-3α-adiol | 4.0 | <0.07 | ? | ? | Estrogen
Ethinyl-3β-androstanediol | 17α-Ethynyl-3β-adiol | 50 | 5.6 | ? | ? | Estrogen
Progesterone | P4; 4-Pregnenedione | <0.001–0.6 | <0.001–0.010 | ? | ? | Progestogen
Norethisterone | NET; 17α-Ethynyl-19-NT | Script error: The function "median" does not exist. (0.0015–<0.1) | Script error: The function "median" does not exist. (0.01–0.3) | 152 | 1084 | Progestogen
Norethynodrel | 5(10)-Norethisterone | Script error: The function "median" does not exist. (0.3–0.7) | <0.1–0.22 | 14 | 53 | Progestogen
Tibolone | 7α-Methylnorethynodrel | Script error: The function "median" does not exist. (0.45–2.0) | 0.2–0.076 | ? | ? | Progestogen
Δ4-Tibolone | 7α-Methylnorethisterone | 0.069–<0.1 | 0.027–<0.1 | ? | ? | Progestogen
3α-Hydroxytibolone | – | Script error: The function "median" does not exist. (1.06–5.0) | 0.6–0.8 | ? | ? | Progestogen
3β-Hydroxytibolone | – | Script error: The function "median" does not exist. (0.75–1.9) | 0.070–0.1 | ? | ? | Progestogen
Footnotes: a = (1) Binding affinity values are of the format "median (range)" (# (#–#)), "range" (#–#), or "value" (#) depending on the values available. The full sets of values within the ranges can be found in the Wiki code. (2) Binding affinities were determined via displacement studies in a variety of in-vitro systems with labeled estradiol and human ERα and ERβ proteins (except the ERβ values from Kuiper et al. (1997), which are rat ERβ). Sources: See template page.

Template:Relative affinities of estrogens for steroid hormone receptors and blood proteins

Template:Affinities and estrogenic potencies of estrogen esters and ethers at the estrogen receptors

v * d * e Selected biological properties of endogenous estrogens in rats  Estrogen | ER RBA (%) | Uterine weight (%) | Uterotrophy | LH levels (%) | SHBG RBA (%)

|
|
|
|
|

Control | – | 100 | – | 100 | –
Estradiol | 100 | 506 ± 20 | +++ | 12–19 | 100
Estrone | 11 ± 8 | 490 ± 22 | +++ | ? | 20
Estriol | 10 ± 4 | 468 ± 30 | +++ | 8–18 | 3
Estetrol | 0.5 ± 0.2 | ? | Inactive | ? | 1
17α-Estradiol | 4.2 ± 0.8 | ? | ? | ? | ?
2-Hydroxyestradiol | 24 ± 7 | 285 ± 8 | +b | 31–61 | 28
2-Methoxyestradiol | 0.05 ± 0.04 | 101 | Inactive | ? | 130
4-Hydroxyestradiol | 45 ± 12 | ? | ? | ? | ?
4-Methoxyestradiol | 1.3 ± 0.2 | 260 | ++ | ? | 9
4-Fluoroestradiola | 180 ± 43 | ? | +++ | ? | ?
2-Hydroxyestrone | 1.9 ± 0.8 | 130 ± 9 | Inactive | 110–142 | 8
2-Methoxyestrone | 0.01 ± 0.00 | 103 ± 7 | Inactive | 95–100 | 120
4-Hydroxyestrone | 11 ± 4 | 351 | ++ | 21–50 | 35
4-Methoxyestrone | 0.13 ± 0.04 | 338 | ++ | 65–92 | 12
16α-Hydroxyestrone | 2.8 ± 1.0 | 552 ± 42 | +++ | 7–24 | <0.5
2-Hydroxyestriol | 0.9 ± 0.3 | 302 | +b | ? | ?
2-Methoxyestriol | 0.01 ± 0.00 | ? | Inactive | ? | 4
Notes: Values are mean ± SD or range. ER RBA = Relative binding affinity to estrogen receptors of rat uterine cytosol. Uterine weight = Percentage change in uterine wet weight of ovariectomized rats after 72 hours with continuous administration of 1 μg/hour via subcutaneously implanted osmotic pumps. LH levels = Luteinizing hormone levels relative to baseline of ovariectomized rats after 24 to 72 hours of continuous administration via subcutaneous implant. Footnotes: a = Synthetic (i.e., not endogenous). b = Atypical uterotrophic effect which plateaus within 48 hours (estradiol's uterotrophy continues linearly up to 72 hours). Sources: See template.

### Overview of actions

This section is in list format, but may read better as prose. You can help by converting this section, if appropriate. Editing help is available. (October 2019)

|

* Musculoskeletal
* Anabolic: Increases muscle mass and strength, speed of muscle regeneration, and bone density, increased sensitivity to exercise, protection against muscle damage, stronger collagen synthesis, increases the collagen content of connective tissues, tendons, and ligaments, but also decreases stiffness of tendons and ligaments (especially during menstruation). Decreased stiffness of tendons gives women much lower predisposition to muscle strains but soft ligaments are much more prone to injuries (ACL tears are 2-8x more common among women than men).[26][27][28][29]
* Reduce bone resorption, increase bone formation[30][31]
* In mice, estrogen has been shown to restore the proportion of type IIX muscle fibers to over 40% following an ovariectomy.[32]
* Metabolic
* Anti-inflammatory properties
* Accelerate metabolism
* Gynoid fat distribution: increased fat storage or estrogenic fat in some body parts such as breasts, buttocks, and legs but decreased abdominal and visceral fat (androgenic obesity).[33][34][35]
* Estradiol also regulates energy expenditure, body weight homeostasis, and seems to have much stronger anti-obesity effects than testosterone in general.[36]
* Inhibition of ferroptosis by hydroxyoestradiol derivatives.[37]
* Other structural
* Maintenance of vessels and skin
* Protein synthesis
* Increase hepatic production of binding proteins
* Increase production of the hepatokine adropin.[38]
* Suppress the transcription of ether-lipid pathway proteins.[37]
* Coagulation
* Increase circulating level of factors 2, 7, 9, 10, plasminogen
* Decrease antithrombin III
* Increase platelet adhesiveness
* Increase vWF (estrogen -> Angiotensin II -> Vasopressin)
* Increase PAI-1 and PAI-2 also through Angiotensin II
* Lipid
* Increase HDL, triglyceride
* Decrease LDL, fat deposition
* Fluid balance
* Salt (sodium) and water retention, including facial swelling and edema[39][40]
* Estrogen is associated with edema, including facial and abdominal swelling.
* Melanin
* Estrogen is known to cause darkening of skin, especially in the face and areolae.[41] Pale skinned women will develop browner and yellower skin during pregnancy, as a result of the increase of estrogen, known as the "mask of pregnancy".[42] Estrogen may explain why women have darker eyes than men, and also a lower risk of skin cancer than men; a European study found that women generally have darker skin than men.[43][44]
* Lung function
* Promotes lung function by supporting alveoli (in rodents but probably in humans).[45]
* Kidney function
* Protects from acute kidney injury in females.[37]
* Sexual
* Mediate formation of female secondary sex characteristics
* Stimulate endometrial growth
* Increase uterine growth
* Increase vaginal lubrication
* Thicken the vaginal wall
* Uterus lining
* Estrogen together with progesterone promotes and maintains the uterus lining in preparation for implantation of fertilized egg and maintenance of uterus function during gestation period, also upregulates oxytocin receptor in myometrium
* Ovulation
* Surge in estrogen level induces the release of luteinizing hormone, which then triggers ovulation by releasing the egg from the Graafian follicle in the ovary.
* Sexual behavior
* Estrogen is required for female mammals to engage in lordosis behavior during estrus (when animals are "in heat").[46][47] This behavior is required for sexual receptivity in these mammals and is regulated by the ventromedial nucleus of the hypothalamus.[48]
* Sex drive is dependent on androgen levels[49] only in the presence of estrogen. Without estrogen, free testosterone level actually decreases sexual desire (instead of increasing sex drive), as demonstrated for those women who have hypoactive sexual desire disorder, and the sexual desire in these women can be restored by administration of estrogen (using oral contraceptive).[50]

### Female pubertal development

Estrogens are responsible for the development of female secondary sexual characteristics during puberty, including breast development, widening of the hips, and female fat distribution. Conversely, androgens are responsible for pubic and body hair growth, as well as acne and axillary odor.

#### Breast development

Estrogen, in conjunction with growth hormone (GH) and its secretory product insulin-like growth factor 1 (IGF-1), is critical in mediating breast development during puberty, as well as breast maturation during pregnancy in preparation of lactation and breastfeeding.[51][52] Estrogen is primarily and directly responsible for inducing the ductal component of breast development,[53][54][55] as well as for causing fat deposition and connective tissue growth.[53][54] It is also indirectly involved in the lobuloalveolar component, by increasing progesterone receptor expression in the breasts[53][55][56] and by inducing the secretion of prolactin.[57][58] Allowed for by estrogen, progesterone and prolactin work together to complete lobuloalveolar development during pregnancy.[54][59]

Androgens such as testosterone powerfully oppose estrogen action in the breasts, such as by reducing estrogen receptor expression in them.[60][61]

### Female reproductive system

Estrogens are responsible for maturation and maintenance of the vagina and uterus, and are also involved in ovarian function, such as maturation of ovarian follicles. In addition, estrogens play an important role in regulation of gonadotropin secretion. For these reasons, estrogens are required for female fertility.[citation needed][62]

### Neuroprotection and DNA repair

Estrogen regulated DNA repair mechanisms in the brain have neuroprotective effects.[63] Estrogen regulates the transcription of DNA base excision repair genes as well as the translocation of the base excision repair enzymes between different subcellular compartments.

### Brain and behavior

#### Sex drive

See also: Philosophy:Sexual motivation and hormones

Estrogens are involved in libido (sex drive) in both women and men.

#### Cognition

Verbal memory scores are frequently used as one measure of higher level cognition. These scores vary in direct proportion to estrogen levels throughout the menstrual cycle, pregnancy, and menopause. Furthermore, estrogens when administered shortly after natural or surgical menopause prevents decreases in verbal memory. In contrast, estrogens have little effect on verbal memory if first administered years after menopause.[64] Estrogens also have positive influences on other measures of cognitive function.[65] However the effect of estrogens on cognition is not uniformly favorable and is dependent on the timing of the dose and the type of cognitive skill being measured.[66]

The protective effects of estrogens on cognition may be mediated by estrogen's anti-inflammatory effects in the brain.[67] Studies have also shown that the Met allele gene and level of estrogen mediates the efficiency of prefrontal cortex dependent working memory tasks.[68][69] Researchers have urged for further research to illuminate the role of estrogen and its potential for improvement on cognitive function.[70]

#### Mental health

Estrogen is considered to play a significant role in women's mental health. Sudden estrogen withdrawal, fluctuating estrogen, and periods of sustained low estrogen levels correlate with a significant lowering of mood. Clinical recovery from postpartum, perimenopause, and postmenopause depression has been shown to be effective after levels of estrogen were stabilized and/or restored.[71][72][73] Menstrual exacerbation (including menstrual psychosis) is typically triggered by low estrogen levels,[74] and is often mistaken for premenstrual dysphoric disorder.[75]

Compulsions in male lab mice, such as those in obsessive-compulsive disorder (OCD), may be caused by low estrogen levels. When estrogen levels were raised through the increased activity of the enzyme aromatase in male lab mice, OCD rituals were dramatically decreased. Hypothalamic protein levels in the gene COMT are enhanced by increasing estrogen levels which are believed to return mice that displayed OCD rituals to normal activity. Aromatase deficiency is ultimately suspected which is involved in the synthesis of estrogen in humans and has therapeutic implications in humans having obsessive-compulsive disorder.[76]

Local application of estrogen in the rat hippocampus has been shown to inhibit the re-uptake of serotonin. Contrarily, local application of estrogen has been shown to block the ability of fluvoxamine to slow serotonin clearance, suggesting that the same pathways which are involved in SSRI efficacy may also be affected by components of local estrogen signaling pathways.[77]

#### Parenthood

Studies have also found that fathers had lower levels of cortisol and testosterone but higher levels of estrogen (estradiol) than did non-fathers.[78]

#### Binge eating

Estrogen may play a role in suppressing binge eating. Hormone replacement therapy using estrogen may be a possible treatment for binge eating behaviors in females. Estrogen replacement has been shown to suppress binge eating behaviors in female mice.[79] The mechanism by which estrogen replacement inhibits binge-like eating involves the replacement of serotonin (5-HT) neurons. Women exhibiting binge eating behaviors are found to have increased brain uptake of neuron 5-HT, and therefore less of the neurotransmitter serotonin in the cerebrospinal fluid.[80] Estrogen works to activate 5-HT neurons, leading to suppression of binge like eating behaviors.[79]

It is also suggested that there is an interaction between hormone levels and eating at different points in the female menstrual cycle. Research has predicted increased emotional eating during hormonal flux, which is characterized by high progesterone and estradiol levels that occur during the mid-luteal phase. It is hypothesized that these changes occur due to brain changes across the menstrual cycle that are likely a genomic effect of hormones. These effects produce menstrual cycle changes, which result in hormone release leading to behavioral changes, notably binge and emotional eating. These occur especially prominently among women who are genetically vulnerable to binge eating phenotypes.[81]

Binge eating is associated with decreased estradiol and increased progesterone.[82] Klump et al.[83] Progesterone may moderate the effects of low estradiol (such as during dysregulated eating behavior), but that this may only be true in women who have had clinically diagnosed binge episodes (BEs). Dysregulated eating is more strongly associated with such ovarian hormones in women with BEs than in women without BEs.[83]

The implantation of 17β-estradiol pellets in ovariectomized mice significantly reduced binge eating behaviors and injections of GLP-1 in ovariectomized mice decreased binge-eating behaviors.[79]

The associations between binge eating, menstrual-cycle phase and ovarian hormones correlated.[82][84][85]

#### Masculinization in rodents

In rodents, estrogens (which are locally aromatized from androgens in the brain) play an important role in psychosexual differentiation, for example, by masculinizing territorial behavior;[86] the same is not true in humans.[87] In humans, the masculinizing effects of prenatal androgens on behavior (and other tissues, with the possible exception of effects on bone) appear to act exclusively through the androgen receptor.[88] Consequently, the utility of rodent models for studying human psychosexual differentiation has been questioned.[89]

### Skeletal system

Estrogens are responsible for both the pubertal growth spurt, which causes an acceleration in linear growth, and epiphyseal closure, which limits height and limb length, in both females and males. In addition, estrogens are responsible for bone maturation and maintenance of bone mineral density throughout life. Due to hypoestrogenism, the risk of osteoporosis increases during menopause.[90]

### Cardiovascular system

Women are less impacted by heart disease due to vasculo-protective action of estrogen which helps in preventing atherosclerosis.[91] It also helps in maintaining the delicate balance between fighting infections and protecting arteries from damage thus lowering the risk of cardiovascular disease.[92] During pregnancy, high levels of estrogens increase coagulation and the risk of venous thromboembolism. Estrogen has been shown to upregulate the peptide hormone adropin.[38]

Template:Venous thromboembolism incidence during pregnancy and the postpartum period

### Immune system

The effect of estrogen on the immune system is in general described as Th2 favoring, rather than suppressive, as is the case of the effect of male sex hormone – testosterone.[93] Indeed, women respond better to vaccines, infections and are generally less likely to develop cancer, the tradeoff of this is that they are more likely to develop an autoimmune disease.[94] The Th2 shift manifests itself in a decrease of cellular immunity and increase in humoral immunity (antibody production) shifts it from cellular to humoral by downregulating cell-mediated immunity and enhancing Th2 immune response by stimulating IL-4 production and Th2 differentiation.[93][95] Type 1 and type 17 immune responses are downregulated, likely to be at least partially due to IL-4, which inhibits Th1. Effect of estrogen on different immune cells' cell types is in line with its Th2 bias. Activity of basophils, eosinophils, M2 macrophages and is enhanced, whereas activity of NK cells is downregulated. Conventional dendritic cells are biased towards Th2 under the influence of estrogen, whereas plasmacytoid dendritic cells, key players in antiviral defence, have increased IFN-g secretion.[95] Estrogen also influences B cells by increasing their survival, proliferation, differentiation and function, which corresponds with higher antibody and B cell count generally detected in women.[96]

On a molecular level estrogen induces the above-mentioned effects on cell via acting on intracellular receptors termed ER α and ER β, which upon ligation form either homo or heterodimers. The genetic and nongenetic targets of the receptors differ between homo and heterodimers.[97] Ligation of these receptors allows them to translocate to the nucleus and act as transcription factors either by binding estrogen response elements (ERE) on DNA or binding DNA together with other transcriptional factors e.g. Nf-kB or AP-1, both of which result in RNA polymerase recruitment and further chromatin remodelation.[97] A non-transcriptional response to oestrogen stimulation was also documented (termed membrane-initiated steroid signalling, MISS). This pathway stimulates the ERK and PI3K/AKT pathways, which are known to increase cellular proliferation and affect chromatin remodelation.[97]

### Associated conditions

Researchers have implicated estrogens in various estrogen-dependent conditions, such as ER-positive breast cancer, as well as a number of genetic conditions involving estrogen signaling or metabolism, such as estrogen insensitivity syndrome, aromatase deficiency, and aromatase excess syndrome.[citation needed]

High estrogen can amplify stress-hormone responses in stressful situations.[98]

## Biochemistry

### Biosynthesis

Steroidogenesis, showing estrogens at bottom right as in pink triangle[99]

Estrogens, in females, are produced primarily by the ovaries, and during pregnancy, the placenta.[100] Follicle-stimulating hormone (FSH) stimulates the ovarian production of estrogens by the granulosa cells of the ovarian follicles and corpora lutea. Some estrogens are also produced in smaller amounts by other tissues such as the liver, pancreas, bone, adrenal glands, skin, brain, adipose tissue,[101] and the breasts.[102] These secondary sources of estrogens are especially important in postmenopausal women.[103] The pathway of estrogen biosynthesis in extragonadal tissues is different. These tissues are not able to synthesize C19 steroids, and therefore depend on C19 supplies from other tissues[103] and the level of aromatase.[104]

In females, synthesis of estrogens starts in theca interna cells in the ovary, by the synthesis of androstenedione from cholesterol. Androstenedione is a substance of weak androgenic activity which serves predominantly as a precursor for more potent androgens such as testosterone as well as estrogen. This compound crosses the basal membrane into the surrounding granulosa cells, where it is converted either immediately into estrone, or into testosterone and then estradiol in an additional step. The conversion of androstenedione to testosterone is catalyzed by 17β-hydroxysteroid dehydrogenase (17β-HSD), whereas the conversion of androstenedione and testosterone into estrone and estradiol, respectively is catalyzed by aromatase, enzymes which are both expressed in granulosa cells. In contrast, granulosa cells lack 17α-hydroxylase and 17,20-lyase, whereas theca cells express these enzymes and 17β-HSD but lack aromatase. Hence, both granulosa and theca cells are essential for the production of estrogen in the ovaries.[citation needed]

Estrogen levels vary through the menstrual cycle, with levels highest near the end of the follicular phase just before ovulation.

Note that in males, estrogen is also produced by the Sertoli cells when FSH binds to their FSH receptors.

v * d * e Production rates, secretion rates, clearance rates, and blood levels of major sex hormones  Sex  | Sex hormone  | Reproductive
phase  | Blood
production rate  | Gonadal
secretion rate  | Metabolic
clearance rate  | Reference range (serum levels)

|
|
|
|
|
|

SI units  | Non-SI units
Men  | Androstenedione |

| 2.8 mg/day  | 1.6 mg/day  | 2200 L/day  | 2.8–7.3 nmol/L  | 80–210 ng/dL
Testosterone |

| 6.5 mg/day  | 6.2 mg/day  | 950 L/day  | 6.9–34.7 nmol/L  | 200–1000 ng/dL
Estrone |

| 150 μg/day  | 110 μg/day  | 2050 L/day  | 37–250 pmol/L  | 10–70 pg/mL
Estradiol |

| 60 μg/day  | 50 μg/day  | 1600 L/day  | <37–210 pmol/L  | 10–57 pg/mL
Estrone sulfate |

| 80 μg/day  | Insignificant  | 167 L/day  | 600–2500 pmol/L  | 200–900 pg/mL
Women  | Androstenedione |

| 3.2 mg/day  | 2.8 mg/day  | 2000 L/day  | 3.1–12.2 nmol/L  | 89–350 ng/dL
Testosterone |

| 190 μg/day  | 60 μg/day  | 500 L/day  | 0.7–2.8 nmol/L  | 20–81 ng/dL
Estrone | Follicular phase  | 110 μg/day  | 80 μg/day  | 2200 L/day  | 110–400 pmol/L  | 30–110 pg/mL
Luteal phase  | 260 μg/day  | 150 μg/day  | 2200 L/day  | 310–660 pmol/L  | 80–180 pg/mL
Postmenopause  | 40 μg/day  | Insignificant  | 1610 L/day  | 22–230 pmol/L  | 6–60 pg/mL
Estradiol | Follicular phase  | 90 μg/day  | 80 μg/day  | 1200 L/day  | <37–360 pmol/L  | 10–98 pg/mL
Luteal phase  | 250 μg/day  | 240 μg/day  | 1200 L/day  | 699–1250 pmol/L  | 190–341 pg/mL
Postmenopause  | 6 μg/day  | Insignificant  | 910 L/day  | <37–140 pmol/L  | 10–38 pg/mL
Estrone sulfate | Follicular phase  | 100 μg/day  | Insignificant  | 146 L/day  | 700–3600 pmol/L  | 250–1300 pg/mL
Luteal phase  | 180 μg/day  | Insignificant  | 146 L/day  | 1100–7300 pmol/L  | 400–2600 pg/mL
Progesterone | Follicular phase  | 2 mg/day  | 1.7 mg/day  | 2100 L/day  | 0.3–3 nmol/L  | 0.1–0.9 ng/mL
Luteal phase  | 25 mg/day  | 24 mg/day  | 2100 L/day  | 19–45 nmol/L  | 6–14 ng/mL

Notes and sources

Notes: "The concentration of a steroid in the circulation is determined by the rate at which it is secreted from glands, the rate of metabolism of precursor or prehormones into the steroid, and the rate at which it is extracted by tissues and metabolized. The secretion rate of a steroid refers to the total secretion of the compound from a gland per unit time. Secretion rates have been assessed by sampling the venous effluent from a gland over time and subtracting out the arterial and peripheral venous hormone concentration. The metabolic clearance rate of a steroid is defined as the volume of blood that has been completely cleared of the hormone per unit time. The production rate of a steroid hormone refers to entry into the blood of the compound from all possible sources, including secretion from glands and conversion of prohormones into the steroid of interest. At steady state, the amount of hormone entering the blood from all sources will be equal to the rate at which it is being cleared (metabolic clearance rate) multiplied by blood concentration (production rate = metabolic clearance rate × concentration). If there is little contribution of prohormone metabolism to the circulating pool of steroid, then the production rate will approximate the secretion rate." Sources: See template.

### Distribution

Estrogens are plasma protein bound to albumin and/or sex hormone-binding globulin in the circulation.

### Metabolism

Estrogens are metabolized via hydroxylation by cytochrome P450 enzymes such as CYP1A1 and CYP3A4 and via conjugation by estrogen sulfotransferases (sulfation) and UDP-glucuronyltransferases (glucuronidation). In addition, estradiol is dehydrogenated by 17β-hydroxysteroid dehydrogenase into the much less potent estrogen estrone. These reactions occur primarily in the liver, but also in other tissues.[105]

v * d * e Estrogen metabolism in humans[106][107][108]

Estradiol

Estrone sulfate

Estrone glucuronide

2-Hydroxyestrone

Estrone

4-Hydroxyestrone

2-Methoxyestrone

16α-Hydroxyestrone

4-Methoxyestrone

17-Epiestriol

Estriol

16-Epiestriol

DeepSkyBlue">17β-HSD

DeepSkyBlue">EST

DeepSkyBlue">STS

DeepSkyBlue">UGT1A3
UGT1A9

CYP450

CYP450

DeepSkyBlue">COMT

CYP450

DeepSkyBlue">COMT

unidentified

DeepSkyBlue">17β-HSD

unidentified

This diagram illustrates the metabolic pathways involved in the metabolism of estrogens (i.e., estradiol, estrone, and estriol) in humans.

### Excretion

Estrogens are inactivated primarily by the kidneys and liver and excreted via the gastrointestinal tract[109] in the form of conjugates, found in feces, bile, and urine.[110]

## Medical use

Main article: Chemistry:Estrogen (medication)

Estrogens are used as medications, mainly in hormonal contraception, hormone replacement therapy,[111] and to treat gender dysphoria in transgender women and other transfeminine individuals as part of feminizing hormone therapy.[112]

## Chemistry

See also: Chemistry:List of estrogens

The estrogen steroid hormones are estrane steroids.[citation needed]

## History

In 1929, Adolf Butenandt and Edward Adelbert Doisy independently isolated and purified estrone, the first estrogen to be discovered.[113] Then, estriol and estradiol were discovered in 1930 and 1933, respectively. Shortly following their discovery, estrogens, both natural and synthetic, were introduced for medical use. Examples include estriol glucuronide (Emmenin, Progynon), estradiol benzoate, conjugated estrogens (Premarin), diethylstilbestrol, and ethinylestradiol.

The word estrogen derives from Ancient Greek. It is derived from "oestros"[114] (a periodic state of sexual activity in female mammals), and genos (generating).[114] It was first published in the early 1920s and referenced as "oestrin".[115] With the years, American English adapted the spelling of estrogen to fit with its phonetic pronunciation.

## Society and culture

### Etymology

The name estrogen is derived from the Greek οἶστρος (oîstros), literally meaning "verve" or "inspiration" but figuratively sexual passion or desire,[116] and the suffix -gen, meaning "producer of".

### Environment

A range of synthetic and natural substances that possess estrogenic activity have been identified in the environment and are referred to xenoestrogens.[117]

* Synthetic substances such as bisphenol A as well as metalloestrogens (e.g., cadmium).
* Plant products with estrogenic activity are called phytoestrogens (e.g., coumestrol, daidzein, genistein, miroestrol).
* Those produced by fungi are known as mycoestrogens (e.g., zearalenone).

Estrogens are among the wide range of endocrine-disrupting compounds because they have high estrogenic potency. When an endocrine-disrupting compound makes its way into the environment, it may cause male reproductive dysfunction to wildlife and humans.[12][13] The estrogen excreted from farm animals makes its way into fresh water systems.[118][119] During the germination period of reproduction the fish are exposed to low levels of estrogen which may cause reproductive dysfunction to male fish.[120][121]

### Cosmetics

Some hair shampoos on the market include estrogens and placental extracts; others contain phytoestrogens. In 1998, there were case reports of four prepubescent African-American girls developing breasts after exposure to these shampoos.[122] In 1993, the FDA determined that not all over-the-counter topically applied hormone-containing drug products for human use are generally recognized as safe and effective and are misbranded. An accompanying proposed rule deals with cosmetics, concluding that any use of natural estrogens in a cosmetic product makes the product an unapproved new drug and that any cosmetic using the term "hormone" in the text of its labeling or in its ingredient statement makes an implied drug claim, subjecting such a product to regulatory action.[123]

In addition to being considered misbranded drugs, products claiming to contain placental extract may also be deemed to be misbranded cosmetics if the extract has been prepared from placentas from which the hormones and other biologically active substances have been removed and the extracted substance consists principally of protein. The FDA recommends that this substance be identified by a name other than "placental extract" and describing its composition more accurately because consumers associate the name "placental extract" with a therapeutic use of some biological activity.[123]

## See also

* List of steroid abbreviations
* Breastfeeding and fertility
* Vasoprotective

## References

1. ↑ 1.0 1.1 1.2 Understanding Pathophysiology. Elsevier Health Sciences. 2019. p. 767. ISBN 978-0-32-367281-8. https://books.google.com/books?id=oF2yDwAAQBAJ&pg=PA767. "Estrogen is a generic term for any of three similar hormones derived from cholesterol: estradiol, estrone, and estriol."
2. ↑ Pharmacology and Pharmacotherapeutics. Elsevier Health Sciences. 2017. p. 943. ISBN 978-8-13-124941-3. https://books.google.com/books?id=f9LQDwAAQBAJ&pg=PA943. "The natural estrogens are steroids. However, typical estrogenic activity is also shown by chemicals which are not steroids. Hence, the term 'estrogen' is used as a generic term to describe all the compounds having estrogenic activity."
3. ↑ "Estrogen". StatPearls [Internet]. StatPearls Publishing. 20 December 2021. https://www.ncbi.nlm.nih.gov/books/NBK538260/. "Estrogen is a steroid hormone associated with the female reproductive organs and is responsible for the development of female sexual characteristics. Estrogen is often referred to as estrone, estradiol, and estriol. ... Synthetic estrogen is also available for clinical use, designed to increase absorption and effectiveness by altering the estrogen chemical structure for topical or oral administration. Synthetic steroid estrogens include ethinyl estradiol, estradiol valerate, estropipate, conjugate esterified estrogen, and quinestrol."
4. ↑ "Biochemistry of aromatase: significance to female reproductive physiology". Cancer Research 42 (8 Suppl): 3342s–3344s. August 1982. PMID 7083198.
5. ↑ "Estrogens in insects". Cellular and Molecular Life Sciences 40 (9): 942–944. September 2005. doi:10.1007/BF01946450.
6. ↑ "Androgen production in women". Fertility and Sterility 77 (Suppl 4): S3–S5. April 2002. doi:10.1016/S0015-0282(02)02985-0. PMID 12007895.
7. ↑ "Estrogens and health in males". Molecular and Cellular Endocrinology 178 (1–2): 51–55. June 2001. doi:10.1016/S0303-7207(01)00420-8. PMID 11403894.
8. ↑ Endocrinology: an integrated approach. Oxford: BIOS: Taylor & Francis. 2001. ISBN 978-1-85996-252-7. https://www.ncbi.nlm.nih.gov/books/NBK22/?depth=10.
9. ↑ "Membrane estrogen receptors – is it an alternative way of estrogen action?". Journal of Physiology and Pharmacology 64 (2): 129–142. April 2013. PMID 23756388.
10. ↑ "Membrane estrogen receptor regulation of hypothalamic function". Neuroendocrinology 96 (2): 103–110. 2012. doi:10.1159/000338400. PMID 22538318.
11. ↑ "GPR30: A G protein-coupled receptor for estrogen". Molecular and Cellular Endocrinology 265–266: 138–142. February 2007. doi:10.1016/j.mce.2006.12.010. PMID 17222505.
12. ↑ 12.0 12.1 "Analysis of steroidal estrogen residues in food and environmental samples". International Journal of Environmental Analytical Chemistry 88 (1): 1–25. 2008. doi:10.1080/03067310701597293. Bibcode: 2008IJEAC..88....1W.
13. ↑ 13.0 13.1 Reproductive and developmental toxicology. New York: Marcel Dekker. 1998. ISBN 0-585-15807-X. OCLC 44957536.
14. ↑ A. Labhart (6 December 2012). Clinical Endocrinology: Theory and Practice. Springer Science & Business Media. pp. 548–. ISBN 978-3-642-96158-8. https://books.google.com/books?id=DAgJCAAAQBAJ&pg=PA548.
15. ↑ "What are the physiological estrogens?". Steroids 78 (3): 337–340. March 2013. doi:10.1016/j.steroids.2012.12.011. PMID 23313336.
16. ↑ "DHEA metabolites activate estrogen receptors alpha and beta". Steroids 78 (1): 15–25. January 2013. doi:10.1016/j.steroids.2012.10.002. PMID 23123738.
17. ↑ "Comparison of pharmacokinetics of a conjugated equine estrogen preparation (premarin) and a synthetic mixture of estrogens (C.E.S.) in postmenopausal women". Journal of the Society for Gynecologic Investigation 7 (3): 175–183. 2000. doi:10.1016/s1071-5576(00)00049-6. PMID 10865186.
18. ↑ "Reference ranges for estradiol, progesterone, luteinizing hormone and follicle-stimulating hormone during the menstrual cycle". WikiJournal of Medicine 1 (1). 2014. doi:10.15347/wjm/2014.001. ISSN 2002-4436.
19. ↑ "Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells". Genome Biology 5 (9). 2004. doi:10.1186/gb-2004-5-9-r66. PMID 15345050.
20. ↑ "Effect of estrogen receptor β A1730G polymorphism on ABCA1 gene expression response to postmenopausal hormone replacement therapy". Genetic Testing and Molecular Biomarkers 15 (1–2): 11–15. 2011. doi:10.1089/gtmb.2010.0106. PMID 21117950.
21. ↑ Counseling the Nursing Mother: A Lactation Consultant's Guide. Jones & Bartlett Learning, LLC. 2004. p. 93. ISBN 978-0-7637-2765-9. https://books.google.com/books?id=Krm2RwGEYjEC&pg=PA93. Retrieved 12 October 2023.
22. ↑ "Science News Online (12/6/97): Estrogen's Emerging Manly Alter Ego". Science News. 6 December 1997. http://www.sciencenews.org/pages/sn_arc97/12_6_97/fob1.htm. Retrieved 4 March 2008.
23. ↑ "A role for oestrogens in the male reproductive system". Nature 390 (6659): 509–512. December 1997. doi:10.1038/37352. PMID 9393999. Bibcode: 1997Natur.390..509H.
24. ↑ "Estrogen Linked To Sperm Count, Male Fertility". Science Blog. http://www.scienceblog.com/community/older/1997/B/199701564.html.
25. ↑ "Estrogen deficiency leads to apoptosis in dopaminergic neurons in the medial preoptic area and arcuate nucleus of male mice". Molecular and Cellular Neurosciences 27 (4): 466–476. December 2004. doi:10.1016/j.mcn.2004.04.012. PMID 15555924.
26. ↑ "Effect of Estrogen on Musculoskeletal Performance and Injury Risk". Frontiers in Physiology 9. 2018. doi:10.3389/fphys.2018.01834. PMID 30697162.
27. ↑ "Mechanisms behind estrogen's beneficial effect on muscle strength in females". Exercise and Sport Sciences Reviews 38 (2): 61–67. April 2010. doi:10.1097/JES.0b013e3181d496bc. PMID 20335737.
28. ↑ "Androgen-estrogen synergy in rat levator ani muscle: glucose-6-phosphate dehydrogenase". Molecular and Cellular Endocrinology 38 (2–3): 103–107. December 1984. doi:10.1016/0303-7207(84)90108-4. PMID 6510548.
29. ↑ "Tamoxifen and oestrogen both protect the rat muscle against physiological damage". The Journal of Steroid Biochemistry and Molecular Biology 40 (4–6): 689–695. 1991. doi:10.1016/0960-0760(91)90292-d. PMID 1958566.
30. ↑ Gavali, Shubhangi; Gupta, Manoj Kumar; Daswani, Bhavna; Wani, Mohan R.; Sirdeshmukh, Ravi; Khatkhatay, M. Ikram (2019). "LYN, a key mediator in estrogen-dependent suppression of osteoclast differentiation, survival, and function" (in en). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1865 (3): 547–557. doi:10.1016/j.bbadis.2018.12.016. PMID 30579930. https://linkinghub.elsevier.com/retrieve/pii/S0925443918305027.
31. ↑ Gavali, Shubhangi; Gupta, Manoj Kumar; Daswani, Bhavna; Wani, Mohan R.; Sirdeshmukh, Ravi; Khatkhatay, M. Ikram (2019). "Estrogen enhances human osteoblast survival and function via promotion of autophagy". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1866 (9): 1498–1507. doi:10.1016/j.bbamcr.2019.06.014. PMID 31255720. https://linkinghub.elsevier.com/retrieve/pii/S0167488919301065.
32. ↑ "Sex-based differences in skeletal muscle kinetics and fiber-type composition". Physiology 30 (1): 30–39. January 2015. doi:10.1152/physiol.00024.2014. PMID 25559153. "Supplementation with estrogen increases the type-IIX percentage composition in the plantaris back to 42%. (70)"
33. ↑ "Determinants of body fat distribution in humans may provide insight about obesity-related health risks". Journal of Lipid Research 60 (10): 1710–1719. October 2019. doi:10.1194/jlr.R086975. PMID 30097511.
34. ↑ "Metabolic impact of sex hormones on obesity". Brain Research 1350: 77–85. September 2010. doi:10.1016/j.brainres.2010.04.056. PMID 20441773.
35. ↑ "Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study". Obesity 18 (3): 604–610. March 2010. doi:10.1038/oby.2009.251. PMID 19696765.
36. ↑ "Estrogens and Body Weight Regulation in Men". Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity. Advances in Experimental Medicine and Biology. 1043. Springer. 2017. pp. 285–313. doi:10.1007/978-3-319-70178-3_14. ISBN 978-3-319-70177-6.
37. ↑ 37.0 37.1 37.2 Tonnus, Wulf; Maremonti, Francesca; Gavali, Shubhangi; Schlecht, Marlena Nastassja; Gembardt, Florian; Belavgeni, Alexia; Leinung, Nadja; Flade, Karolin et al. (September 2025). "Multiple oestradiol functions inhibit ferroptosis and acute kidney injury" (in en). Nature 645 (8082): 1011–1019. doi:10.1038/s41586-025-09389-x. ISSN 1476-4687. PMID 40804518. Bibcode: 2025Natur.645.1011T.
38. ↑ 38.0 38.1 "Hepatic adropin is regulated by estrogen and contributes to adverse metabolic phenotypes in ovariectomized mice". Molecular Metabolism 60. June 2022. doi:10.1016/j.molmet.2022.101482. PMID 35364299.
39. ↑ "Reasons Why Your Face Looks Swollen" (in en). https://www.webmd.com/allergies/ss/slideshow-swollen-face.
40. ↑ "Sex hormone effects on body fluid regulation". Exercise and Sport Sciences Reviews 36 (3): 152–159. July 2008. doi:10.1097/JES.0b013e31817be928. PMID 18580296.
41. ↑ Histology: A Text and Atlas: With Correlated Cell and Molecular Biology. Wolters Kluwer Health. 2023. p. 1481. ISBN 978-1-9751-8152-9. https://books.google.com/books?id=dCrKEAAAQBAJ&pg=PT1481. Retrieved 12 October 2023.
42. ↑ "Conception, Pregnancy, and Birth". Exploring the Dimensions of Human Sexuality. Jones & Bartlett Learning. 2014. p. 248. ISBN 978-1-4496-4851-0. https://books.google.com/books?id=hm3aTuANFroC&pg=PA248. Retrieved 12 October 2023.
43. ↑ "Researchers discover genetic causes of higher melanoma risk in men" (in en). ScienceDaily. https://www.sciencedaily.com/releases/2016/07/160721072753.htm.
44. ↑ "Sex-specific genetic effects associated with pigmentation, sensitivity to sunlight, and melanoma in a population of Spanish origin". Biology of Sex Differences 7 (1). 18 March 2016. doi:10.1186/s13293-016-0070-1. PMID 26998216. "The results of this study suggest that there are indeed sex-specific genetic effects in human pigmentation, with larger effects for darker pigmentation in females compared to males. A plausible cause might be the differentially expressed melanogenic genes in females due to higher oestrogen levels. These sex-specific genetic effects would help explain the presence of darker eye and skin pigmentation in females, as well as the well-known higher melanoma risk displayed by males."
45. ↑ "Estrogen regulates pulmonary alveolar formation, loss, and regeneration in mice". American Journal of Physiology. Lung Cellular and Molecular Physiology 287 (6): L1154–L1159. December 2004. doi:10.1152/ajplung.00228.2004. PMID 15298854. http://pdfs.semanticscholar.org/65aa/5f698c0b57e4d3746dace1af255260ebeae5.pdf.
46. ↑ "Hormonal regulation of female reproduction". Hormone and Metabolic Research 44 (8): 587–591. July 2012. doi:10.1055/s-0032-1306301. PMID 22438212.
47. ↑ "Roles for oestrogen receptor β in adult brain function". Journal of Neuroendocrinology 24 (1): 160–173. January 2012. doi:10.1111/j.1365-2826.2011.02206.x. PMID 21851428.
48. ↑ "Mapping of neural and signal transduction pathways for lordosis in the search for estrogen actions on the central nervous system". Behavioural Brain Research 92 (2): 169–180. May 1998. doi:10.1016/S0166-4328(97)00189-7. PMID 9638959.
49. ↑ "Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women". Menopause 12 (4): 374–384. 2005. doi:10.1097/01.GME.0000153933.50860.FD. PMID 16037752.
50. ↑ "Sexual desire, sexual arousal and hormonal differences in premenopausal US and Dutch women with and without low sexual desire". Hormones and Behavior 59 (5): 772–779. May 2011. doi:10.1016/j.yhbeh.2011.03.013. PMID 21514299.
51. ↑ "Hormone action in the mammary gland". Cold Spring Harbor Perspectives in Biology 2 (12). December 2010. doi:10.1101/cshperspect.a003178. PMID 20739412.
52. ↑ "Role of IGF-I in normal mammary development". Breast Cancer Research and Treatment 47 (3): 201–208. February 1998. doi:10.1023/a:1005998832636. PMID 9516076.
53. ↑ 53.0 53.1 53.2 Essential Medical Physiology. Academic Press. 2003. p. 770. ISBN 978-0-12-387584-6. https://books.google.com/books?id=j9e-tkdHeUoC&pg=PA770.
54. ↑ 54.0 54.1 54.2 Hormones. Academic Press. 30 July 2014. p. 311. ISBN 978-0-08-091906-5. https://books.google.com/books?id=_renonjXq68C&pg=PA311.
55. ↑ 55.0 55.1 Anatomy and Physiology for Midwives, with Pageburst online access,3: Anatomy and Physiology for Midwives. Elsevier Health Sciences. 2011. p. 413. ISBN 978-0-7020-3489-3. https://books.google.com/books?id=OmSKoYD-iW0C&pg=PA413.
56. ↑ Hormones and Breast Cancer in Post-Menopausal Women. IOS Press. 1 January 2006. p. 69. ISBN 978-1-58603-653-9. https://books.google.com/books?id=wGaKtDw50K0C&pg=PA69.
57. ↑ Color Atlas of Physiology. Thieme. 1 January 2011. pp. 305–. ISBN 978-3-13-149521-1. https://books.google.com/books?id=WyuCGhv4kvwC&pg=PA305.
58. ↑ High-yield Comprehensive USMLE Step 1 Review. Lippincott Williams & Wilkins. 2007. pp. 445–. ISBN 978-0-7817-7427-7. https://books.google.com/books?id=d-MxROzDPgcC&pg=PA445.
59. ↑ Maternal, Fetal, & Neonatal Physiology. Elsevier Health Sciences. 14 April 2014. pp. 146–. ISBN 978-0-323-29296-2. https://books.google.com/books?id=RNLsAwAAQBAJ&pg=PA146.
60. ↑ Yen and Jaffe's Reproductive Endocrinology. Elsevier Health Sciences. 13 September 2013. pp. 236–. ISBN 978-1-4557-2758-2. https://books.google.com/books?id=KZ95AAAAQBAJ&pg=PA236.
61. ↑ Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant. Elsevier Health Sciences. 24 February 2015. pp. 190–. ISBN 978-0-323-24147-2. https://books.google.com/books?id=VuZ1BwAAQBAJ&pg=PA190.
62. ↑ Greene, Jim (2022). "Estrogen". https://www.ebsco.com/research-starters/health-and-medicine/estrogen.
63. ↑ "Role of Estrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair". Frontiers in Aging Neuroscience 9. 2017. doi:10.3389/fnagi.2017.00430. PMID 29311911.
64. ↑ "Estrogen and cognitive functioning in women: lessons we have learned". Behavioral Neuroscience 126 (1): 123–127. February 2012. doi:10.1037/a0025539. PMID 22004260.
65. ↑ "Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse". Physiological Reviews 95 (3): 785–807. July 2015. doi:10.1152/physrev.00036.2014. PMID 26109339.
66. ↑ "Estrogens and cognition: Friends or foes?: An evaluation of the opposing effects of estrogens on learning and memory". Hormones and Behavior 74: 105–115. August 2015. doi:10.1016/j.yhbeh.2015.06.017. PMID 26149525.
67. ↑ "Estrogens, inflammation and cognition". Frontiers in Neuroendocrinology 40: 87–100. January 2016. doi:10.1016/j.yfrne.2016.01.002. PMID 26774208.
68. ↑ "Estrogen shapes dopamine-dependent cognitive processes: implications for women's health". The Journal of Neuroscience 31 (14): 5286–5293. April 2011. doi:10.1523/JNEUROSCI.6394-10.2011. PMID 21471363.
69. ↑ "Effects of estrogen on higher-order cognitive functions in unstressed human females may depend on individual variation in dopamine baseline levels". Frontiers in Neuroscience 8: 65. 1 January 2014. doi:10.3389/fnins.2014.00065. PMID 24778605.
70. ↑ "Estrogen and the brain: does estrogen treatment improve cognitive function?". Menopause International 19 (1): 6–19. March 2013. doi:10.1177/1754045312473873. PMID 27951525.
71. ↑ "Estrogen-related mood disorders: reproductive life cycle factors". ANS. Advances in Nursing Science 28 (4): 364–375. 2005. doi:10.1097/00012272-200510000-00008. PMID 16292022.
72. ↑ "Estrogen action in mood and neurodegenerative disorders: estrogenic compounds with selective properties-the next generation of therapeutics". Endocrine 28 (3): 235–242. December 2005. doi:10.1385/ENDO:28:3:235. PMID 16388113.
73. ↑ "The effects of estradiol on central serotonergic systems and its relationship to mood in women". Biological Research for Nursing 9 (2): 147–160. October 2007. doi:10.1177/1099800407305600. PMID 17909167.
74. ↑ "The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women". Canadian Journal of Psychiatry 47 (5): 437–442. June 2002. doi:10.1177/070674370204700504. PMID 12085678.
75. ↑ "PMDD/PMS". https://womensmentalhealth.org/specialty-clinics/pms-and-pmdd/.
76. ↑ "Estrogen deficient male mice develop compulsive behavior". Biological Psychiatry 61 (3): 359–366. February 2007. doi:10.1016/j.biopsych.2006.01.012. PMID 16566897.
77. ↑ "Comparison of the effects of estradiol and progesterone on serotonergic function". Biological Psychiatry 71 (7): 633–641. April 2012. doi:10.1016/j.biopsych.2011.11.023. PMID 22225849.
78. ↑ "Changes in testosterone, cortisol, and estradiol levels in men becoming fathers". Mayo Clinic Proceedings 76 (6): 582–592. June 2001. doi:10.4065/76.6.582. PMID 11393496.
79. ↑ 79.0 79.1 79.2 "Estrogens stimulate serotonin neurons to inhibit binge-like eating in mice". The Journal of Clinical Investigation 124 (10): 4351–4362. October 2014. doi:10.1172/JCI74726. PMID 25157819.
80. ↑ "Eating disorders and depression: is there a serotonin connection?". Biological Psychiatry 28 (5): 443–454. September 1990. doi:10.1016/0006-3223(90)90412-u. PMID 2207221.
81. ↑ "The interactive effects of estrogen and progesterone on changes in emotional eating across the menstrual cycle". Journal of Abnormal Psychology 122 (1): 131–137. February 2013. doi:10.1037/a0029524. PMID 22889242.
82. ↑ 82.0 82.1 "Ovarian hormones and binge eating in bulimia nervosa". Psychological Medicine 37 (1): 131–141. January 2007. doi:10.1017/S0033291706008956. PMID 17038206.
83. ↑ 83.0 83.1 "Ovarian Hormone Influences on Dysregulated Eating: A Comparison of Associations in Women with versus without Binge Episodes". Clinical Psychological Science 2 (4): 545–559. September 2014. doi:10.1177/2167702614521794. PMID 25343062.
84. ↑ "Ovarian hormones and binge eating: exploring associations in community samples". Psychological Medicine 38 (12): 1749–1757. December 2008. doi:10.1017/S0033291708002997. PMID 18307829.
85. ↑ "Symptom fluctuation in bulimia nervosa: relation to menstrual-cycle phase and cortisol levels". Psychological Medicine 33 (1): 51–60. January 2003. doi:10.1017/s0033291702006815. PMID 12537036.
86. ↑ "Estrogen masculinizes neural pathways and sex-specific behaviors". Cell 139 (1): 61–72. October 2009. doi:10.1016/j.cell.2009.07.036. PMID 19804754.
87. ↑ "Aromatase deficiency in men: a clinical perspective". Nature Reviews. Endocrinology 5 (10): 559–568. October 2009. doi:10.1038/nrendo.2009.176. PMID 19707181. https://zenodo.org/record/890683.
88. ↑ "Androgens, androgen receptors, and male gender role behavior". Hormones and Behavior 40 (2): 358–366. September 2001. doi:10.1006/hbeh.2001.1684. PMID 11534997. http://pdfs.semanticscholar.org/75bb/071beb950f66cd032b9d5a9633c255f80660.pdf.
89. ↑ "Mammalian animal models of psychosexual differentiation: when is 'translation' to the human situation possible?". Hormones and Behavior 50 (4): 579–588. November 2006. doi:10.1016/j.yhbeh.2006.06.003. PMID 16876166.
90. ↑ Cheng, Chu-Han; Chen, Li-Ru; Chen, Kuo-Hu (2022-01-25). "Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover". International Journal of Molecular Sciences 23 (3): 1376. doi:10.3390/ijms23031376. ISSN 1422-0067. PMID 35163300.
91. ↑ "Oestrogens and the heart". Therapie 54 (3): 381–385. 1999. PMID 10500455.
92. ↑ "Activation of the annexin A1 pathway underlies the protective effects exerted by estrogen in polymorphonuclear leukocytes". Arteriosclerosis, Thrombosis, and Vascular Biology 31 (11): 2749–2759. November 2011. doi:10.1161/ATVBAHA.111.235176. PMID 21836070.
93. ↑ 93.0 93.1 "The effects of sex hormones on immune function: a meta-analysis". Biological Reviews of the Cambridge Philosophical Society 92 (1): 551–571. February 2017. doi:10.1111/brv.12243. PMID 26800512. https://api.research-repository.uwa.edu.au/ws/files/21601252/Foo_et_al_2017_The_effects_of_sex_hormones_on_immune_function_a_meta_analysis.pdf.
94. ↑ "Sex Hormones Determine Immune Response". Frontiers in Immunology 9. 27 August 2018. doi:10.3389/fimmu.2018.01931. PMID 30210492.
95. ↑ 95.0 95.1 "Sex differences in immune responses: Hormonal effects, antagonistic selection, and evolutionary consequences". Hormones and Behavior 88: 95–105. February 2017. doi:10.1016/j.yhbeh.2016.11.017. PMID 27956226.
96. ↑ "The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases". Frontiers in Immunology 6: 635. 6 January 2016. doi:10.3389/fimmu.2015.00635. PMID 26779182.
97. ↑ 97.0 97.1 97.2 "Estrogen receptors regulate innate immune cells and signaling pathways". Cellular Immunology 294 (2): 63–69. April 2015. doi:10.1016/j.cellimm.2015.01.018. PMID 25682174.
98. ↑ Estrogen's Storm Season: stories of perimenopause. Vancouver, British Columbia: CeMCOR (Centre for Menstrual Cycle and Ovulation Research). 2018. ISBN 978-0-9738275-2-1. https://books.google.com/books?id=2hFFDwAAQBAJ. Retrieved 24 July 2021. "[...] high estrogen amplifies your stress hormone responses to stressful things [...]"
99. ↑ "Diagram of the pathways of human steroidogenesis". WikiJournal of Medicine 1 (1). 2014. doi:10.15347/wjm/2014.005. ISSN 2002-4436.
100. ↑ Anatomy & physiology. Benjamin-Cummings. 2013. p. 903. ISBN 978-0-321-88760-3.
101. ↑ "Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age". The Journal of Clinical Endocrinology and Metabolism 38 (3): 476–479. March 1974. doi:10.1210/jcem-38-3-476. PMID 4815174.
102. ↑ "Extra-gonadal sites of estrogen biosynthesis and function". BMB Reports 49 (9): 488–496. September 2016. doi:10.5483/BMBRep.2016.49.9.141. PMID 27530684.
103. ↑ 103.0 103.1 "Estrogen production and action". Journal of the American Academy of Dermatology 45 (3 Suppl): S116–S124. September 2001. doi:10.1067/mjd.2001.117432. PMID 11511861.
104. ↑ "DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging". Steroids 63 (5–6): 322–328. 1998. doi:10.1016/S0039-128X(98)00007-5. PMID 9618795.
105. ↑ Hu, Shiwan; Ding, Qiyou; Zhang, Wei; Kang, Mengjiao; Ma, Jing; Zhao, Linhua (2023-12-31). "Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism". Gut Microbes 15 (1). doi:10.1080/19490976.2023.2236749. ISSN 1949-0976. https://www.tandfonline.com/doi/full/10.1080/19490976.2023.2236749.
106. ↑ The Menopause (Clinical Perspectives in Obstetrics and Gynecology). New York, NY: Springer Science & Business Media. 2012. p. 64. ISBN 9781461255253. https://books.google.com/books?id=z0LuBwAAQBAJ&pg=PA64|date=6#v=onepage&q&f=false.
107. ↑ "Pharmacology of estrogens and progestogens: influence of different routes of administration". Climacteric : the Journal of the International Menopause Society 8 Suppl 1: 3–63. August 2005. doi:10.1080/13697130500148875. PMID 16112947.
108. ↑ "EC 2.4.1.17 – glucuronosyltransferase and Organism(s) Homo sapiens". EC 2.4.1.17 – glucuronosyltransferase and Organism(s) Homo sapiens. Technische Universität Braunschweig. January 2018. https://www.brenda-enzymes.org/enzyme.php?ecno=2.4.1.17&Suchword=estrone&reference=&UniProtAcc=&organism[]=Homo+sapiens. Retrieved 10 August 2018.
109. ↑ "The Ovary". Clinical Endocrinology: Theory and Practice. Springer Berlin Heidelberg. 2012. p. 530. ISBN 978-3-642-96158-8. https://books.google.com/books?id=DAgJCAAAQBAJ&pg=PA530. Retrieved 12 October 2023.
110. ↑ "Estrogen receptor signaling mechanisms". Advances in Protein Chemistry and Structural Biology. 116. Elsevier. 2019. pp. 135–170. doi:10.1016/bs.apcsb.2019.01.001. ISBN 978-0-12-815561-5. "Physiologically, the metabolic conversion of estrogens allows their excretion from the body via urine, feces, and/or bile, along with the production of estrogen analogs, which have been shown to present antiproliferative effects (Tsuchiya et al., 2005)."
111. ↑ "Pharmacology of estrogens and progestogens: influence of different routes of administration". Climacteric 8 (Suppl 1): 3–63. August 2005. doi:10.1080/13697130500148875. PMID 16112947.
112. ↑ "Hormonal and Surgical Treatment Options for Transgender Women and Transfeminine Spectrum Persons". The Psychiatric Clinics of North America 40 (1): 99–111. March 2017. doi:10.1016/j.psc.2016.10.006. PMID 28159148.
113. ↑ "One hundred years of hormones". EMBO Reports 6 (6): 490–496. June 2005. doi:10.1038/sj.embor.7400444. PMID 15940278.
114. ↑ 114.0 114.1 "Origin in Biomedical Terms: oestrogen or oestrogen". http://bioetymology.blogspot.com.au/2011/03/estrogen-or-oestrogen.html.
115. ↑ "Council on Pharmacy and Chemistry". Journal of the American Medical Association 107 (15): 1221–3. 1936. doi:10.1001/jama.1936.02770410043011.
116. ↑ "Greek Word Study Tool: oistros". Perseus Digital Library. https://www.perseus.tufts.edu/hopper/morph?l=oistros&la=greek.
117. ↑ "Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens". Chemical Research in Toxicology 14 (3): 280–294. March 2001. doi:10.1021/tx000208y. PMID 11258977.
118. ↑ "Are oral contraceptives a significant contributor to the estrogenicity of drinking water?". Environmental Science & Technology 45 (1): 51–60. January 2011. doi:10.1021/es1014482. PMID 20977246.
119. ↑ "Don't Blame The Pill | Latest News". Chemical & Engineering News. https://pubsapp.acs.org/cen/news/88/i44/8844news4.html.
120. ↑ "Assessing the sensitivity of different life stages for sexual disruption in roach (Rutilus rutilus) exposed to effluents from wastewater treatment works". Environmental Health Perspectives 113 (10): 1299–1307. October 2005. doi:10.1289/ehp.7921. PMID 16203238. Bibcode: 2005EnvHP.113.1299L.
121. ↑ "Predicted exposures to steroid estrogens in U.K. rivers correlate with widespread sexual disruption in wild fish populations". Environmental Health Perspectives 114 (Suppl 1): 32–39. April 2006. doi:10.1289/ehp.8050. PMID 16818244. Bibcode: 2006EnvHP.114S..32J.
122. ↑ "Preschool Puberty, and a Search for the Causes". The New York Times. 17 October 2006. https://www.nytimes.com/2006/10/17/science/17puberty.html.
123. ↑ 123.0 123.1 FDA (February 1995). "Products containing estrogenic hormones, placental extract or vitamins". Guide to Inspections of Cosmetic Product Manufacturers. https://www.fda.gov/ora/inspect_ref/igs/cosmet.html.

## External links

* Nussey and Whitehead: Endocrinology, an integrated approach, Taylor and Francis 2001. Free online textbook.

* v
* t
* e

Estradiol

Topics|

* Estradiol (as a hormone)
* Estradiol (as a medication)
* Pharmacodynamics of estradiol
* Pharmacokinetics of estradiol
* Estrogen (as a hormone)
* Estrogen (as a medication)
* Menopausal hormone therapy
* Transgender hormone therapy (male-to-female)
* Estradiol-containing birth control pill
* Combined injectable birth control
* High-dose estrogen
* Hydroxylation of estradiol

Esters|

* Estrogen ester
* Estradiol ester
* Estradiol acetate
* Estradiol benzoate
* Estradiol benzoate butyrate
* Estradiol cypionate
* Estradiol dipropionate
* Estradiol enantate
* Estradiol undecylate
* Estradiol valerate
* Polyestradiol phosphate
* Estramustine phosphate (estradiol normustine phosphate)

Related|

* Estrone
* Estriol
* Estetrol
* Ethinylestradiol
* Conjugated estrogens
* Esterified estrogens
* Estrone sulfate
* Estropipate (piperazine estrone sulfate)

* v
* t
* e

Hormones

Endocrine
glands|

| Hypothalamic-
pituitary|

| Hypothalamus|

* GnRH
* TRH
* Dopamine
* CRH
* GHRH
* Somatostatin (GHIH)
* MCH

|

Posterior pituitary|

* Oxytocin
* Vasopressin

Anterior pituitary|

* FSH
* LH
* TSH
* Prolactin
* POMC
* CLIP
* ACTH
* MSH
* Endorphins
* Lipotropin
* GH

Adrenal axis|

* Adrenal cortex
* Aldosterone
* Cortisol
* Cortisone
* DHEA
* DHEA-S
* Androstenedione
* Adrenal medulla
* Epinephrine
* Norepinephrine

Thyroid|

* Thyroid hormones
* T3
* T4
* Calcitonin
* Thyroid axis

Parathyroid|

* PTH

Gonadal axis|

| Testis|

* Testosterone
* AMH
* Inhibin

|

Ovary|

* Estradiol
* Progesterone
* Activin
* Inhibin
* Relaxin
* GnSAF

Placenta|

* hCG
* HPL
* Estrogen
* Progesterone

Pancreas|

* Glucagon
* Insulin
* Amylin
* Somatostatin
* Pancreatic polypeptide

Pineal gland|

* Melatonin
* N,N-Dimethyltryptamine
* 5-Methoxy-N,N-dimethyltryptamine

Other|

| Thymus|

* Thymosins
* Thymosin α1
* Beta thymosins
* Thymopoietin
* Thymulin

|

Digestive system|

| Stomach|

* Gastrin
* Ghrelin

|

Duodenum|

* CCK
* Incretins
* GIP
* GLP-1
* Secretin
* Motilin
* VIP

Ileum|

* Enteroglucagon
* Peptide YY

Liver/other|

* Insulin-like growth factor
* IGF-1
* IGF-2

Adipose tissue|

* Leptin
* Adiponectin
* Resistin

Skeleton|

* Osteocalcin

Kidney|

* Renin
* EPO
* Calcitriol
* Prostaglandin

Heart|

* Natriuretic peptide
* ANP
* BNP

* v
* t
* e

Endogenous steroids

Precursors|

* Cholesterol
* 22R-Hydroxycholesterol
* 20α,22R-Dihydroxycholesterol
* Pregnenolone
* 11β-Hydroxypregnenolone
* 17α-Hydroxypregnenolone
* 21-Hydroxypregnenolone
* 17α,21-Dihydroxypregnenolone
* 11β,17α,21-Trihydroxypregnenolone

Corticosteroids|

| Glucocorticoids|

* 3α,5α-Tetrahydrocorticosterone
* 5α-Dihydrocorticosterone
* 11-Deoxycorticosterone
* 11-Deoxycortisol
* 11-Ketoprogesterone
* 21-Deoxycortisol
* 21-Deoxycortisone
* Corticosterone
* Cortisol
* Cortisone
* 17α-Hydroxypregnenolone
* 17α-Hydroxyprogesterone
* Pregnenolone
* Progesterone

* Metabolites: 5α-Dihydrocortisol
* 3α,5α-Tetrahydrocortisol

|

Mineralocorticoids|

* 5α-Dihydroaldosterone
* 11-Dehydrocorticosterone (11-oxocorticosterone, 17-deoxycortisone)
* 11-Deoxycortisol
* 11-Deoxycorticosterone
* 11β-Hydroxyprogesterone (21-deoxycorticosterone)
* 18-Hydroxy-11-deoxycorticosterone
* 18-Hydroxycorticosterone
* 18-Hydroxyprogesterone
* Aldosterone
* Corticosterone
* Cortisol

Sex steroids|

| Androgens|

* 11-Ketodihydrotestosterone
* 11-Ketotestosterone
* 7β-Hydroxyepiandrosterone
* 11β-Hydroxyandrostenedione
* Adrenosterone (11-ketoandrostenedione)
* Androstenediol
* Androstenedione
* Androsterone
* Dehydroandrosterone
* DHEA
* DHEA sulfate
* Dihydrotestosterone
* Epiandrosterone
* Epitestosterone
* 16α-Hydroxyandrostenedione
* 16α-Hydroxy-DHEA
* 16α-Hydroxy-DHEA sulfate
* Testosterone

* Metabolites: 3α-Androstanediol
* 3α-Androstanediol glucuronide
* 3β-Androstanediol
* 5β-Dihydrotestosterone
* 3α-Etiocholanediol
* 3β-Etiocholanediol
* Androstanetriols
* Androstenediol sulfate
* Androsterone glucuronide
* Androsterone sulfate
* Dihydrotestosterone glucuronide
* Dihydrotestosterone sulfate
* Etiocholanedione
* Etiocholanolone
* Etiocholanolone glucuronide
* Epietiocholanolone
* Testosterone glucuronide
* Testosterone sulfate

|

Estrogens|

* Estranes: Estetrol
* Estradiol
* Estrone
* Estriol
* 17α-Estradiol
* 16β-Epiestriol (16β-hydroxyestradiol)
* 17α-Epiestriol (16α-hydroxy-17α-estradiol)
* 16β,17α-Epiestriol (16β-hydroxy-17α-estradiol)
* 2-Hydroxyestradiol
* 2-Hydroxyestriol
* 2-Hydroxyestrone
* 4-Hydroxyestradiol
* 4-Hydroxyestriol
* 4-Hydroxyestrone
* 4-Methoxyestradiol
* 16α-Hydroxyestrone

* Others: 27-Hydroxycholesterol
* 3α-Androstanediol
* 3β-Androstanediol
* 4-Androstenedione
* 5-Androstenediol
* DHEA
* DHEA sulfate
* 7-Keto-DHEA
* 7α-Hydroxy-DHEA
* 16α-Hydroxy-DHEA

* Metabolites: 2-Methoxyestradiol
* 2-Methoxyestrone
* 4-Methoxyestrone
* Estradiol glucuronide
* Estradiol 3-glucuronide
* Estradiol sulfate
* Estradiol 17β-sulfate
* Estrone glucuronide
* Estrone sulfate
* Estriol glucuronide
* Estriol sulfate
* Lipoidal estradiol (e.g., estradiol stearate, estradiol palmitate)

Progestogens|

* Progesterone
* 16α-Hydroxyprogesterone
* 17α-Hydroxyprogesterone
* 20α-Dihydroprogesterone
* 20β-Dihydroprogesterone
* 5α-Dihydroprogesterone
* 11-Deoxycorticosterone
* 5α-DHDOC

* Metabolites: Allopregnanediol
* Pregnanediol
* Pregnanediol glucuronide
* Pregnanetriol

Neurosteroids|

* Cholestanes: 24S-Hydroxycholesterol
* Cholesterol

* Pregnanes: 3α-Dihydroprogesterone
* 3β-Dihydroprogesterone
* 5α-Dihydrocorticosterone
* 5α-Dihydroprogesterone
* 5β-Dihydroprogesterone
* Allopregnanolone
* Corticosterone
* DHC
* DHDOC
* 11-Deoxycorticosterone
* Epipregnanolone
* Isopregnanolone
* Pregnanolone
* Pregnenolone
* Pregnenolone sulfate
* Progesterone
* THB
* THDOC

* Androstanes: 3α-Androstanediol
* 3α-Androstenol
* 7-Keto-DHEA
* 7α-Hydroxy-DHEA
* 7β-Hydroxy-DHEA
* 7α-Hydroxyepiandrosterone
* 7β-Hydroxyepiandrosterone
* Androsterone
* DHEA
* DHEA sulfate
* Etiocholanolone

* Pheromones: 3α-Androstenol
* 3β-Androstenol
* Androstadienol
* Androstadienone
* Androstenone
* Androsterone
* Estratetraenol

Others|

* Vitamin D: 7-Dehydrocholesterol
* Calcidiol/Calcifediol
* Calcitriol
* Cholecalciferol

* Others: 7α-Hydroxycholesterol
* 11α-Hydroxyprogesterone
* 11β-Hydroxyprogesterone
* Cholesterol sulfate

* v
* t
* e

Estrogens and antiestrogens

Estrogens|

| ER agonists|

* Steroidal: Alfatradiol
* Certain androgens/anabolic steroids (e.g., testosterone, testosterone esters, methyltestosterone, metandienone, nandrolone esters) (via estrogenic metabolites)
* Certain progestins (e.g., norethisterone, noretynodrel, etynodiol diacetate]], tibolone)
* Clomestrone
* Cloxestradiol acetate
* Conjugated estriol
* Conjugated estrogens
* Epiestriol
* Epimestrol
* Esterified estrogens
* Estetrol†
* Estradiol
* Estradiol esters (e.g., estradiol acetate, estradiol benzoate, estradiol cypionate, estradiol enanthate, estradiol undecylate, [[Chemistry:Estradiol estradiol valerate, Polyestradiol phosphate|polyestradiol phosphate]], estradiol ester mixtures (Climacteron))
* Estramustine phosphate
* Estriol
* Estriol esters (e.g., estriol succinate, polyestriol phosphate)
* Estrone
* Estrone esters
* Estrone sulfate
* Estropipate (piperazine estrone sulfate)
* Ethinylestradiol#
* Ethinylestradiol sulfonate
* Hydroxyestrone diacetate
* Mestranol
* Methylestradiol
* Moxestrol
* Nilestriol
* Prasterone (dehydroepiandrosterone; DHEA)
* Prasterone enanthate
* Prasterone sulfate
* Promestriene
* Quinestradol
* Quinestrol

* Nonsteroidal: Benzestrol
* Bifluranol
* Chlorotrianisene
* Dienestrol
* Dienestrol diacetate
* Diethylstilbestrol (stilbestrol)
* Diethylstilbestrol esters/ethers
* Dimestrol (diethylstilbestrol dimethyl ether)
* Fosfestrol (diethylstilbestrol diphosphate)
* Mestilbol (diethylstilbestrol monomethyl ether)
* Doisynoestrol (fenocycline)
* Hexestrol
* Hexestrol esters
* Methallenestril
* Methestrol dipropionate (promethestrol dipropionate)
* Paroxypropione
* Quadrosilan
* Triphenylbromoethylene
* Triphenylchloroethylene
* Zeranol

|

Progonadotropins|

* Antiandrogens (e.g., bicalutamide)
* GnRH agonists (e.g., GnRH (gonadorelin), leuprorelin)
* Gonadotropins (e.g., FSH, LH)

Antiestrogens|

| ER antagonists
(incl. SERMs/SERDs)|

* Acolbifene†
* Anordrin
* Bazedoxifene
* Broparestrol
* Clomifene#
* Cyclofenil
* Enclomifene†
* Epitiostanol
* Lasofoxifene
* Mepitiostane
* Ormeloxifene
* Ospemifene
* Raloxifene
* Tamoxifen#
* Toremifene

* Exclusively antagonistic: Fulvestrant

|

Aromatase inhibitors|

* First-generation: Aminoglutethimide
* Testolactone

* Second-generation: Fadrozole
* Formestane

* Third-generation: Anastrozole
* Exemestane
* Letrozole

Antigonadotropins|

* Androgens/Anabolic steroid|Anabolic steroid|Anabolic steroid]]]]s (e.g., testosterone, testosterone esters, nandrolone esters, oxandrolone, fluoxymesterone)
* D2 receptor antagonists (prolactin releasers) (e.g., domperidone, metoclopramide, risperidone, haloperidol, chlorpromazine, sulpiride)
* GnRH agonists (e.g., leuprorelin, goserelin)
* GnRH antagonists (e.g., cetrorelix, elagolix)
* Progestogens (e.g., chlormadinone acetate, cyproterone acetate, gestonorone caproate, hydroxyprogesterone caproate, [[Chemistry:Medroxyprogesterone medroxyprogesterone acetate, Chemistry:Megestrol acetate|megestrol acetate]])

Others|

* Mixed mechanism of action: Danazol
* Gestrinone

* Androstenedione immunogens: Androvax (androstenedione albumin)
* Ovandrotone albumin (Fecundin)

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

See also
Estrogen receptor modulators
Androgens and antiandrogens
Progestogens and antiprogestogens
List of estrogens

* v
* t
* e

Estrogen receptor modulators

ER|

| Agonists|

* Steroidal: 2-Hydroxyestradiol
* 2-Hydroxyestrone
* 3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol
* 3α-Androstanediol
* 3α,5α-Dihydrolevonorgestrel
* 3β,5α-Dihydrolevonorgestrel
* 3α-Hydroxytibolone
* 3β-Hydroxytibolone
* 3β-Androstanediol
* 4-Androstenediol
* 4-Androstenedione
* 4-Hydroxyestradiol
* 4-Hydroxyestrone
* 4-Methoxyestradiol
* 4-Methoxyestrone
* 5-Androstenediol
* 7-Oxo-DHEA
* 7α-Hydroxy-DHEA
* 7α-Methylestradiol
* 7β-Hydroxyepiandrosterone
* 8,9-Dehydroestradiol
* 8,9-Dehydroestrone
* 8β-VE2
* 10β,17β-Dihydroxyestra-1,4-dien-3-one (DHED)
* 16α-Fluoroestradiol
* 16α-Hydroxy-DHEA
* 16α-Hydroxyestrone
* 16α-Iodoestradiol
* 16α-LE2
* 16β,17α-Epiestriol (16β-hydroxy-17α-estradiol)
* 17α-Estradiol (alfatradiol)
* 17α-Dihydroequilenin
* 17α-Dihydroequilin
* 17α-Epiestriol (16α-hydroxy-17α-estradiol)
* 17β-Dihydroequilenin
* 17β-Dihydroequilin
* Abiraterone
* Abiraterone acetate
* Alestramustine
* Almestrone
* Anabolic steroids (e.g., testosterone and esters, methyltestosterone, metandienone (methandrostenolone), nandrolone and esters, many others; via estrogenic metabolites)
* Atrimustine
* Bolandiol
* Bolandiol dipropionate
* Butolame
* Clomestrone
* Cloxestradiol
* Cloxestradiol acetate
* Conjugated estriol
* Conjugated estrogens
* Cyclodiol
* Cyclotriol
* DHEA
* DHEA-S
* Epiestriol (16β-epiestriol, 16β-hydroxy-17β-estradiol)
* Epimestrol
* Equilenin
* Equilin
* ERA-63 (ORG-37663)
* Esterified estrogens
* Estetrol
* Estradiol
* Estradiol esters
* Lipoidal estradiol
* Polyestradiol phosphate
* Estramustine
* Estramustine phosphate
* Estrapronicate
* Estrazinol
* Estriol
* Estriol esters
* Polyestriol phosphate
* Estrofurate
* Estromustine
* Estrone
* Estrone esters
* Estrone methyl ether
* Estropipate
* Etamestrol (eptamestrol)
* Ethinylestradiol
* Ethinylestradiol 3-benzoate
* Ethinylestradiol sulfonate
* Ethinylestriol
* Ethylestradiol
* Etynodiol
* Etynodiol diacetate
* Hexolame
* Hippulin
* Hydroxyestrone diacetate
* Lynestrenol
* Lynestrenol phenylpropionate
* Mestranol
* Methylestradiol
* Moxestrol
* Mytatrienediol
* Nilestriol
* Norethisterone
* Noretynodrel
* Orestrate
* Pentolame
* Prodiame
* Prolame
* Promestriene
* RU-16117
* Quinestradol
* Quinestrol
* Tibolone

* Nonsteroidal: (R,R)-THC
* (S,S)-THC
* 2,8-DHHHC
* β-LGND1
* β-LGND2 (GTx-878)
* AC-186
* Allenestrol
* Allenolic acid
* Benzestrol
* Bifluranol
* Bisdehydrodoisynolic acid
* Carbestrol
* D-15414
* DCW234
* Diarylpropionitrile
* Dienestrol
* Dienestrol diacetate
* Diethylstilbestrol
* Diethylstilbestrol esters
* Dimestrol (dianisylhexene)
* Doisynoestrol (fenocycline)
* Doisynolic acid
* Efavirenz
* ERB-196 (WAY-202196)
* Erteberel (SERBA-1, LY-500307)
* Estrobin (DBE)
* Fenestrel
* FERb 033
* Fosfestrol (diethylstilbestrol diphosphate)
* Furostilbestrol (diethylstilbestrol difuroate)
* GTx-758
* Hexestrol
* Hexestrol esters
* ICI-85966 (Stilbostat)
* Mestilbol
* Methallenestril
* Methestrol
* Methestrol dipropionate
* Paroxypropione
* Pentafluranol
* Phenestrol
* Prinaberel (ERB-041, WAY-202041)
* Propylpyrazoletriol
* Quadrosilan
* SC-4289
* SERBA-2
* SKF-82,958
* Terfluranol
* Triphenylbromoethylene
* Triphenylchloroethylene
* Triphenyliodoethylene
* Triphenylmethylethylene (triphenylpropene)
* WAY-166818
* WAY-169916
* WAY-200070
* WAY-204688 (SIM-688)
* WAY-214156

* Unknown/unsorted: ERB-26
* ERA-45
* ERB-79
* ZK-283197

* Xenoestrogens: Anise-related (e.g., anethole, anol, dianethole, dianol, photoanethole)
* Chalconoids (e.g., isoliquiritigenin, phloretin, phlorizin (phloridzin), wedelolactone)
* Coumestans (e.g., coumestrol, psoralidin)
* Flavonoids (incl. 7,8-DHF, 8-prenylnaringenin, apigenin, baicalein, baicalin, biochanin A, calycosin, catechin, daidzein, daidzin, ECG, EGCG, [[Chemistry:Epicateepicatechin, Chemistry:Equol|equol]], formononetin, glabrene, glabridin, Genistein|genistein]], genistin, glycitein, kaempferol, Chemistry:Liquiritigenin

|

Mixed
(SERMs)|

* 2-Phenylbenzofuran
* 2-Phenylbenzothiophene
* 4'-Hydroxynorendoxifen
* 27-Hydroxycholesterol
* Acefluranol
* Acolbifene
* Afimoxifene
* Anordiol
* Anordrin
* Arzoxifene
* Bazedoxifene
* Brilanestrant
* Broparestrol
* Chlorotrianisene
* Clomifene
* Clomifenoxide
* Cyclofenil
* D-15413
* Droloxifene
* Elacestrant
* Enclomifene
* Endoxifen
* Etacstil (GW-5638, DPC-974)
* Ethamoxytriphetol (MER-25)
* Femarelle
* Fispemifene
* GW-7604
* ICI-55548
* Idoxifene
* Lasofoxifene
* Levormeloxifene
* LN-1643
* LN-2299
* LY-117018
* Menerba
* Miproxifene
* Miproxifene phosphate
* Nafoxidine
* Nitromifene
* NNC 45-0095
* NNC 45-0320
* NNC 45-0781
* NNC 45-1506
* Ormeloxifene
* Ospemifene
* Panomifene
* Pipendoxifene
* Promensil
* Raloxifene
* Rimostil (P-081)
* Spironolactone
* SS1010
* Tamoxifen
* TAS-108 (SR-16234)
* Toremifene
* Trioxifene
* TZE-5323
* Y-134
* Zindoxifene
* Zuclomifene

Antagonists|

* (R,R)-THC
* 7β-Hydroxy-DHEA
* Chloroindazole
* Cytestrol acetate
* EM-800
* Epitiostanol
* ERA-90
* ERB-88
* Fulvestrant (ICI-182780)
* Glyceollins (I, II, III, IV)
* ICI-164384
* Mepitiostane
* Methylepitiostanol
* Methylpiperidinopyrazole
* MIBE
* Oxabicycloheptene sulfonate
* Phenytoin
* PHTPP
* Prochloraz
* RU-58668
* SS1020
* TAS-108 (SR-16234)
* ZB716
* ZK-164015
* ZK-191703

* Coregulator-binding modulators: ERX-11

GPER|

| Agonists|

* 2-Methoxyestradiol
* 7β-Hydroxyepiandrosterone
* Afimoxifene (4-hydroxytamoxifen)
* Atrazine
* Bisphenol A
* Daidzein
* DDT (p,p'-DDT, o',p'-DDE)
* Equol
* Estradiol
* Ethinylestradiol
* Fulvestrant (ICI-182780)
* G-1
* Genistein
* GPER-L1
* GPER-L2
* Hydroxytyrosol
* Kepone
* Niacin
* Nicotinamide
* Nonylphenol
* Oleuropein
* PCBs (2,2',5'-PCB-4-OH)
* Propylpyrazoletriol
* Quercetin
* Raloxifene
* Resveratrol
* Tamoxifen
* Tectoridin
* Zearalanone
* Zearalenol
* Zearalenone
* Zeranol (zearalanol))

|

Antagonists|

* CCL18
* Estriol
* G-15
* G-36
* MIBE

See also
Receptor/signaling modulators
Estrogens and antiestrogens
Androgen receptor modulators
Progesterone receptor modulators
List of estrogens

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Estrogen. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Biology:Estrogen&oldid=4357784"
*[ER]: Estrogen receptor
*[RBA]: Relative binding affinity
*[LH]: luteinizing hormone
*[SHBG]: Sex hormone-binding globulin
*[SI]: Système International
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template
*[GnRH]: gonadotropin-releasing hormone
*[FSH]: follicle-stimulating hormone
*[SERMs]: Selective estrogen receptor modulators
*[SERDs]: selective estrogen receptor downregulators
*[GPER]: G protein-coupled estrogen receptor